Drug delivery modifier Corium International files for a $50 million IPO

By
A A A

Corium International, a commercial stage pharmaceutical company that adapts drugs to wearable delivery systems, filed on Monday with the SEC to raise up to $50 million in an initial public offering. The Menlo Park, CA-based company, which was founded in 1995 and booked $48 million in sales for the 12 months ended December 31, 2013, plans to list on the NASDAQ under the symbol CORI. Corium initially filed confidentially on December 23, 2013. Jefferies and Leerink Partners are the joint bookrunners on the deal. No pricing terms were disclosed.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.




This article appears in: News Headlines , IPOs

Referenced Stocks:

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

What to Wear to a Wedding
What to Wear to a Wedding           
4th of July Outfits
4th of July Outfits                 

Stocks

Referenced

Most Active by Volume

62,287,287
  • $17.03 ▼ 1.10%
26,194,993
  • $30.555 ▲ 1.24%
26,150,957
  • $126.44 ▼ 0.13%
25,197,634
  • $40.59 ▼ 6.26%
25,192,083
  • $19.07 ▲ 1.54%
24,563,617
  • $26.78 ▲ 0.45%
24,474,256
  • $5.85 ▲ 1.56%
24,111,132
  • $8.83 ▲ 2.08%
As of 7/2/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com